These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22001623)

  • 1. [A relevant choice for corticoid eye drops: solution or suspension?].
    Nourry H; Viard C; Cambourieu C; Warnet JM
    J Fr Ophtalmol; 2011 Dec; 34(10):691-6. PubMed ID: 22001623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dosage problems in suspension eyedrops].
    Kwon KA; Diestelhorst M; Süverkrüp R
    Klin Monbl Augenheilkd; 1996; 209(2-3):144-9. PubMed ID: 8992075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose uniformity of ophthalmic suspensions.
    Diestelhorst M; Kwon KA; Süverkrup R
    J Cataract Refract Surg; 1998 May; 24(5):672-7. PubMed ID: 9610452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
    Moya-Ortega MD; Alves TF; Alvarez-Lorenzo C; Concheiro A; Stefánsson E; Thorsteinsdóttir M; Loftsson T
    Int J Pharm; 2013 Jan; 441(1-2):507-15. PubMed ID: 23149258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taste comparison of corticosteroid suspensions.
    Regan TD; Lewis D; Norton SA
    J Drugs Dermatol; 2006 Oct; 5(9):835-7. PubMed ID: 17039647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size and aggregation of corticosteroids used for epidural injections.
    Derby R; Lee SH; Date ES; Lee JH; Lee CH
    Pain Med; 2008 Mar; 9(2):227-34. PubMed ID: 18298706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
    Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension.
    Scoper SV; Kabat AG; Owen GR; Stroman DW; Kabra BP; Faulkner R; Kulshreshtha AK; Rusk C; Bell B; Jamison T; Bernal-Perez LF; Brooks AC; Nguyen VA
    Adv Ther; 2008 Feb; 25(2):77-88. PubMed ID: 18309465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels.
    Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D
    Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast sensitivity and optical quality of the eye after instillation of timolol maleate gel-forming solution and brinzolamide ophthalmic suspension.
    Hiraoka T; Daito M; Okamoto F; Kiuchi T; Oshika T
    Ophthalmology; 2010 Nov; 117(11):2080-7. PubMed ID: 20656353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of corticosteroid eye drops delays the spontaneous remission of pulmonary sarcoidosis.
    Nara M; Sasamori K; Shimura S; Ogawa H; Ishigaki-Suzuki S; Nagaoka M; Tamada T; Ichinose M; Tamura G; Hattori T
    Tohoku J Exp Med; 2004 Apr; 202(4):275-82. PubMed ID: 15109125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L; Zhang J; Wang L; Xia H
    Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new ophthalmic suspension prednisolone acetate 1%.
    Akram M; Shyum SB; Gauhar S
    Pak J Pharm Sci; 2010 Apr; 23(2):149-54. PubMed ID: 20363691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ophthalmic suspensions using surface tension.
    Yasueda S; Inada K; Matsuhisa K; Terayama H; Ohtori A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):377-82. PubMed ID: 15018999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):495-500. PubMed ID: 28339389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose Uniformity of Topical Corticosteroids: A Simulated Trial of Fluorometholone Acetate 0.1% and Loteprednol Etabonate Gel 0.5.
    Stevens CE; Bennion JL; Caldwell MC; Townley JR; Apsey DA; Schwertner HA
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):111-114. PubMed ID: 28140772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension.
    Bessonova J; Meyer-Lindenberg A; Bäumer W; Kietzmann M
    Vet Ophthalmol; 2011 Mar; 14(2):109-13. PubMed ID: 21366826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.